Breaking News Instant updates and real-time market news.

LMNR

Limoneira

$19.32

-0.06 (-0.31%)

08:34
07/11/19
07/11
08:34
07/11/19
08:34

Limoneira JV with Lewis Group announces closing of 30 residential units

Limoneira announced that its 50%/50% real estate development joint venture with Lewis Group has closed 30 residential units with one of the United States leading homebuilders, K. Hovnanian Homes. K. Hovnanian Homes is one of the primary builders for the initial 632 residential units of the company's Harvest at Limoneira project. The company expects to close an additional 33 residential units with K. Hovnanian Homes later this year.

  • 13

    Nov

LMNR Limoneira
$19.32

-0.06 (-0.31%)

09/11/18
LSCM
09/11/18
NO CHANGE
Target $31
LSCM
Buy
Limoneira shares will likely sell off today, says Lake Street
Lake Street analyst Chris Krueger expects shares of Limoneira to sell off today following last night's earnings shortfall on weather. The stock had risen 65% since February and was pricing in expectations of a Q3 beat and guidance increase, neither of which happened, Krueger tells investors in a post-earnings research note. While sales beat estimates, poor weather hurt margins and caused an earnings miss, the analyst explains. However, he remains confident Limoneira will continue to grow its core agribusiness and generate additional cash flow from its real estate and water rights. Krueger raised his price target for the shares to $31 from $30 and keeps Buy rating on the name.
01/08/19
SPHN
01/08/19
INITIATION
Target $24
SPHN
Overweight
Limoneira initiated with an Overweight at Stephens
Stephens analyst Ben Bienvenu initiated coverage of Limoneira with an Overweight rating and $24 price target, stating that it has a unique position and portfolio of assets along with a "compelling" long-term growth story. He sees Limoneira's earnings approaching an inflection point that he expects to begin in FY19, Bienvenu added.
05/14/19
SPHN
05/14/19
DOWNGRADE
Target $18
SPHN
Equal Weight
Limoneira downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Ben Bienvenu downgraded Limoneira to Equal Weight from Overweight and lowered his price target for the shares to $18 from $25. While the company lowered its full year guidance, second half of 2019 expectations remain too aggressive to totally eliminate the risk of another guidance reduction later in the year, Bienvenu tells investors in a research note. The analyst expects Limoneira shares to trade off today given the magnitude of the Q2 miss and lack of visibility into the remainder of fiscal 2019.
05/14/19
LSCM
05/14/19
NO CHANGE
Target $28
LSCM
Buy
Limoneira results hurt by rains in Southern California, says Lake Street
Poor weather hurt Limoneira's lemon and orange businesses in the company's preliminary Q2 results, Lake Street analyst Chris Krueger tells investors in a research note. While the company continues to execute on its global lemon strategy, heavy rains in Southern California caused volatility in its core business, which should normalize in the coming quarters, adds the analyst. He remains confident Limoneira will continue to grow its core agribusiness and generate additional cash flow from its real estate and water rights. Krueger lowered his price target for the shares to $28 from $31 and keeps a Buy rating on Limoneira.

TODAY'S FREE FLY STORIES

COT

Cott Corp.

$12.29

0.005 (0.04%)

07:53
07/23/19
07/23
07:53
07/23/19
07:53
Recommendations
Cott Corp. analyst commentary  »

Cott Corp. pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 25

    Sep

SFM

Sprouts Farmers Market

$17.28

-0.88 (-4.85%)

07:51
07/23/19
07/23
07:51
07/23/19
07:51
Downgrade
Sprouts Farmers Market rating change  »

Sprouts Farmers Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 13

    Nov

VISL

Vislink

$1.01

-0.165 (-14.10%)

07:50
07/23/19
07/23
07:50
07/23/19
07:50
Hot Stocks
Vislink receives orders valued at $1.6M for satellite communications equipment »

Vislink Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$52.87

0.62 (1.19%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Recommendations
Six Flags analyst commentary  »

Six Flags attendance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HAL

Halliburton

$23.76

2.02 (9.29%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 13

    Nov

TIGR

UP Fintech

$4.29

-0.38 (-8.14%)

07:49
07/23/19
07/23
07:49
07/23/19
07:49
Hot Stocks
UP Fintech reports approval for capital markets license in Singapore »

UP Fintech Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$23.76

2.02 (9.29%)

07:48
07/23/19
07/23
07:48
07/23/19
07:48
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 13

    Nov

MARA

Marathon Patent Group

$2.13

-0.08 (-3.62%)

07:48
07/23/19
07/23
07:48
07/23/19
07:48
Hot Stocks
Marathon Patent Group receives Nasdaq acceptance of plan to regain compliance »

Marathon Patent Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$144.97

-0.28 (-0.19%)

, BBBY

Bed Bath & Beyond

$9.35

-0.56 (-5.65%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Recommendations
Wayfair, Bed Bath & Beyond, Macy's analyst commentary  »

Wayfair well positioned…

W

Wayfair

$144.97

-0.28 (-0.19%)

BBBY

Bed Bath & Beyond

$9.35

-0.56 (-5.65%)

M

Macy's

$22.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 05

    Aug

IDRA

Idera Pharmaceuticals

$2.54

0.02 (0.79%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Hot Stocks
Idera Pharmaceuticals appoints Elizabeth Tarka as CMO, John Kirby as CFO »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$225.97

1.455 (0.65%)

07:46
07/23/19
07/23
07:46
07/23/19
07:46
Recommendations
Air Products analyst commentary  »

Air Products price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 22

    Aug

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:45
07/23/19
07/23
07:45
07/23/19
07:45
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Amaryllis study »

The Amaryllis Study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:44
07/23/19
07/23
07:44
07/23/19
07:44
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Magnolia clinical trial »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$60.62

0.77 (1.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Itron analyst commentary  »

Canaccord sees several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:41
07/23/19
07/23
07:41
07/23/19
07:41
Hot Stocks
RedHill Biopharma continues to enroll patients in Phase 2a study of YELIVA »

The ongoing Phase 2a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FBP

First BanCorp

$10.74

-0.25 (-2.27%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Earnings
First BanCorp reports Q2 EPS 19c, consensus 19c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Hot Stocks
RedHill Biopharma 'working toward' confirmatory Phase 3 study for BEKINDA »

RedHill is currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

07:40
07/23/19
07/23
07:40
07/23/19
07:40
General news
Treasury Market Outlook: Treasury yields are modestly cheaper »

Treasury Market Outlook:…

ATI

Allegheny Technologies

$25.11

-0.175 (-0.69%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Earnings
Allegheny Technologies reports Q2 ex-items EPS 40c, consensus 34c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma to initiate Phase 3 study activities with RHB-204 in Q4 »

RedHill plans to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NOW

ServiceNow

$293.30

3.48 (1.20%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Recommendations
ServiceNow analyst commentary at Needham »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma says FDA meetings for RHB-104 to take place in 2H198 »

FDA meetings are planned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:38
07/23/19
07/23
07:38
07/23/19
07:38
Hot Stocks
RedHill Biopharma plans U.S. launch of Talicia in 4Q19 »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CR

Crane

$86.50

0.99 (1.16%)

, CIR

Circor

$39.83

1.17 (3.03%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Recommendations
Crane, Circor analyst commentary  »

Crane Q2 highlighted by…

CR

Crane

$86.50

0.99 (1.16%)

CIR

Circor

$39.83

1.17 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.